Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Enimmune corporation

Market Cap 1.17B 37.08M 31.99M 29.41M 27.68M 52.02M 3.5B 52.46M 349M 136M 1.72B 139M 136M 5.94B P/E 2024
-11.3x
P/E 2025 -9.04x
Enterprise Value 1.12B 35.36M 30.5M 28.04M 26.4M 49.6M 3.34B 50.02M 332M 129M 1.64B 133M 130M 5.67B EV / Sales 2024
35.4x
EV / Sales 2025 29.7x
Free-Float
-
Yield 2024 *
-
Yield 2025 -
1 day-2.99%
1 week-3.56%
Current month-6.61%
1 month-11.20%
3 months-1.52%
6 months-24.42%
Current year-21.12%
1 week 16.25
Extreme 16.25
17.4
1 month 16.25
Extreme 16.25
18.95
Current year 16.1
Extreme 16.1
22.15
1 year 14.65
Extreme 14.65
23.9
3 years 14.65
Extreme 14.65
51.3
5 years 14.65
Extreme 14.65
75.3
10 years 14.49
Extreme 14.49
125
Manager TitleAgeSince
Chief Executive Officer - 2019-01-06
Chief Tech/Sci/R&D Officer - 2014-07-20
Comptroller/Controller/Auditor - -
Director TitleAgeSince
Chairman - 2019-01-06
Director/Board Member - 2014-01-01
Director/Board Member - 2015-05-18
Change 5-day change 1-year change 3-year change Capi.($)
-2.99%-3.56%+1.56%-67.76% 38.31M
+3.23%+2.93%+61.50%+113.87% 54.54B
+0.04%+5.05%+43.44%+36.75% 43.86B
+3.04%+6.61%-13.27%-18.06% 22.63B
+3.07%-0.60%-3.09%+392.25% 20.7B
-0.53%-0.27%+12.68%-37.07% 15.84B
+5.27%+1.71%+11.09%-38.81% 14.83B
+0.65%-1.04%+25.60%+174.70% 13.1B
-5.17%+4.13%+13.12% - 12.66B
-0.27%+4.82%+75.35%+104.79% 11.56B
Average +0.63%-0.47%+22.80%+73.41% 20.98B
Weighted average by Cap. +1.52%+0.18%+31.62%+90.66%

Financials

2024 2025
Net sales 39.92M 1.26M 1.09M 1M 943K 1.77M 119M 1.79M 11.87M 4.62M 58.49M 4.74M 4.64M 202M 48.19M 1.52M 1.32M 1.21M 1.14M 2.14M 144M 2.16M 14.33M 5.58M 70.62M 5.72M 5.6M 244M
Net income -158M -4.98M -4.3M -3.95M -3.72M -6.99M -470M -7.05M -46.85M -18.24M -231M -18.71M -18.31M -799M -164M -5.2M -4.49M -4.12M -3.88M -7.29M -491M -7.35M -48.87M -19.03M -241M -19.51M -19.1M -833M
Net Debt -382M -12.09M -10.43M -9.59M -9.02M -16.95M -1.14B -17.1M -114M -44.22M -560M -45.36M -44.39M -1.94B -54.59M -1.73M -1.49M -1.37M -1.29M -2.42M -163M -2.44M -16.23M -6.32M -80M -6.48M -6.34M -277M
Logo Enimmune corporation
ENIMMUNE CORP. is a Taiwan-based biotechnology new drug company mainly engaged in the development, produce and distribution of new drugs. The Company's new drug products include biological agents, monoclonal antibodies, vaccines, and small molecule drugs. The Company mainly conducts drug testing business, biotechnology service business, international trade business, western medicine wholesale and retail business. The product is Tuberculin PPD.
Employees
-
Date Price Change Volume
26-06-17 16.25 NT$ -2.99% 26,203
26-06-16 16.75 NT$ -3.18% 118,674
26-06-15 17.30 NT$ 0.00% 17,595
26-06-12 17.30 NT$ -0.29% 41,560
26-06-11 17.35 NT$ +2.36% 21,341
  1. Stock Market
  2. Stocks
  3. 6564 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!